Low vit C levels may increase risk for heart failure patients

By Nathan Gray

- Last updated on GMT

Low vit C levels may increase risk for heart failure patients

Related tags: Heart failure, Vitamin c intake, Vitamin c

Heart failure patients with low vitamin C levels could be at higher risk of complications and may also have worse long term outcomes, according to a new research.

Speaking at the American Heart Association's Scientific Sessions 2011​, the researchers reported on the study, which found low levels of vitamin C to be associated with higher levels of high sensitivity C-Reactive protein (hsCRP) and shorter intervals without major cardiac issues or death for heart failure patients.

The research team, led by Dr Eun Kyeung Song from the College of Medicine at the University of Ulsan in Korea, found that patients with the lowest vitamin C levels were 2.4 times more likely to have higher levels of hsCRP than those with the highest levels of the vitamin.

The authors added that study participants with low vitamin C intake and hsCRP over 3 milligrams per liter (mg/L) were nearly twice as likely to die from cardiovascular disease within one year of follow-up.

“We found that adequate intake of vitamin C was associated with longer survival in patients with heart failure,"​ said Song.

"Increased levels of high-sensitivity C-reactive protein means a worsening of heart failure,"​ he added. "An adequate level of vitamin C is associated with lower levels of high-sensitivity C-reactive protein. This results in a longer cardiac event-free survival in patients."

The authors added that the study is the first to demonstrate a link between low vitamin C status and reduced outcomes for heart failure patients.

Study details

Song and his colleagues examined the relationship between vitamin C intake and hsCRP in 212 heart failure patients using a four-day food diary verified by a registered dietitian –a software program then calculated vitamin C intake – and bloods tests to measure hsCRP. The researchers then divided participants into two groups; one with levels over 3 mg/L of hsCRP, and another with lower levels. The patients were followed for one year to determine the length of time to their first visit to the emergency department due to cardiac problems or death.

The researchers found that 39% (82 patients) had inadequate vitamin C intake, according to criteria set by the US Institute of Medicine. After a year follow-up, 29% (61 patients) had cardiac events, including visits to the emergency department or hospitalisation due to cardiac problems, or cardiac death.Song and his team reported that low vitamin C intake was associated with higher level of hsCRP.

“Low vitamin C intake [also] predicted shorter cardiac event-free survival after controlling for age, gender, body mass index, NYHA class, ejection fraction, comorbidities, total caloric intake and medications,”​ they said.

Song added that further research, including randomised controlled trials and longitudinal prospective studies are needed to determine the impact of other micronutrients on survival or rehospitalisation of heart failure patients.

Source: American Heart Association's Scientific Sessions 2011
Session Title: Issues in Heart Failure Management

Abstract 14667: Vitamin C Deficiency, High-Sensitivity C-Reactive Protein, and Cardiac Event-Fee Survival in Patients with Heart Failure

Authors: E.K. Song, D.K. Moser, H. Payne-Emerson. S.B. Dunbar, S.J. Pressler, T.A. Lennie

Related news

Related products

show more

Resveratrol and Sports Nutrition: A Winning Combo

Resveratrol and Sports Nutrition: A Winning Combo

Evolva | 18-Oct-2019 | Technical / White Paper

In addition to physical activity, research indicates that resveratrol can be a key ingredient for top sports performance. Not only has resveratrol been...

Vitamin K2 Success Stories: NattoPharma

Vitamin K2 Success Stories: NattoPharma

NattoPharma USA, Inc. | 23-Sep-2019 | Case Study

Partnership means companies are bound to the process – from formulation and testing to marketing and meeting demand. That is what companies selecting MenaQ7®...

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals and Transparency

Gemini Pharmaceuticals | 01-Sep-2019 | Application Note

The industry has shown improvement in its transparency in the past 5 years. Per the regulations, a Brand Owner is 100% responsible for the quality of...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars